Laboratorios Farmaceuticos Rovi S.A (LABFF PINK) stock market data APIs
$90.61
0(0%)
as of January 14, 2025
Laboratorios Farmaceuticos Rovi S.A Financial Data Overview
Price chart is built with
Anychart
Laboratorios Farmaceuticos Rovi, S.A. engages in the research, development, manufacture, and marketing of pharmaceutical products in Spain and internationally. The company provides products for cardiology, osteoarticular/women's health, anesthesia /pain, diagnostic imaging contrast agents, central nervous system, urology, endocrinology, respiratory, and primary healthcare areas. Its principal products include Ameride, Bertanel, Bluxam, Enoxaparin Rovi, Calcium Vitamine D3 Rovi, Exxiv, Prinvil, Rhodogil, Glufan, Hibor, Hirobriz Breezhaler, Neparvis, Medicebran, Medikinet, Mysimba, Orvatez, Tryptizol, Ulunar Breezhaler, and Volutsa; and hospital products, such as Iomeron and Iopamiro, Multihance and Y Prohance, Sonovue, Empowercta+, Empowermr, and CT Express, Fibrilin, and Sodium Heparin Rovi. It also provides contract-manufacturing services to other companies for a range of pharmaceutical forms, including prefilled syringes, vials, suppositories, tablets, and sachets. Laboratorios Farmaceuticos Rovi, S.A. was incorporated in 1946 and is headquartered in Madrid, Spain. Laboratorios Farmaceúticos Rovi, S.A. is a subsidiary of Norbel Inversiones, S.L.
Prev. Close
90.61
Open
90.61
Volume
0
High
90.61
Low
90.61
52 wk Range
50.6901-90.61
Market Cap
4 635 M
P/E Ratio
28.9489
Shares Outstanding
51 153 K
Revenue
799 M
EPS
1.4986
Dividends (Yield)
0.0132
Beta
0.476
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Laboratorios Farmaceuticos Rovi S.A data using free add-ons & libraries
Get Laboratorios Farmaceuticos Rovi S.A Fundamental Data
Laboratorios Farmaceuticos Rovi S.A Fundamental data includes:
- Net Revenue: 799 M
- EBITDA: 234 M
- Earnings Per Share: 3
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2024-11-07
- EPS/Forecast: NaN
Get Laboratorios Farmaceuticos Rovi S.A End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Laboratorios Farmaceuticos Rovi S.A News
New
Moderna ramps up investments to triple vaccine output, eyes boosters
Moderna (MRNA) is ramping up its investments in production capacity to more than triple its annual COVID-19 vaccine output for 2022, paving the way for more messenger RNA COVID-19 vaccines to be in ci...
Moderna ramps up investments to triple vaccine output, eyes boosters
Moderna (MRNA) is ramping up its investments in production capacity to more than triple its annual COVID-19 vaccine output for 2022, paving the way for more messenger RNA COVID-19 vaccines to be in ci...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
